Status:
UNKNOWN
Aspirin and Enalapril in Microalbuminuric Type 2 Diabetes Mellitus Patients
Lead Sponsor:
Hospital de Clinicas de Porto Alegre
Conditions:
Diabetes Mellitus
Microalbuminuria
Eligibility:
All Genders
30-80 years
Phase:
PHASE4
Brief Summary
Research design: randomized, double-blind, placebo-controlled crossover study to evaluate the putative interference of low-dose aspirin (for 8 weeks) on enalapril antiproteinuric properties in microal...
Detailed Description
Research design: randomized, double-blind, placebo-controlled crossover study Patients: Microalbuminuric (urinary albumin excretion \[UAE\]30-300 mg/d)type 2 diabetes mellitus patients without ischemi...
Eligibility Criteria
Inclusion
- type 2 diabetes mellitus microalbuminuria
Exclusion
- ischemic heart disease peptic disease
Key Trial Info
Start Date :
March 1 2003
Trial Type :
INTERVENTIONAL
End Date :
January 1 2007
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00427271
Start Date
March 1 2003
End Date
January 1 2007
Last Update
January 29 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital de Clínicas de Porto Aelgre
Porto Alegre, Rio Grande do Sul, Brazil, 900035900